Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 4
207
Views
0
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Metabolism of gartanin in liver microsomes and its modulating effects on cytochrome P450s

&
Pages 335-345 | Received 03 Mar 2022, Accepted 09 May 2022, Published online: 24 May 2022

References

  • Aizat WM, Jamil IN, Ahmad-Hashim FH, Noor NM. 2019. Recent updates on metabolite composition and medicinal benefits of mangosteen plant. Peerj. 7:e6324.
  • Azminah A, Erlina L, Radji M, Mun'Im A, Syahdi RR, Yanuar A. 2019. In silico and in vitro identification of candidate SIRT1 activators from Indonesian medicinal plants compounds database. Comput Biol Chem. 83:107096.
  • Chatuphonprasert W, Jarukamjorn K. 2012. Impact of six fruits-banana, guava, mangosteen, pineapple, ripe mango and ripe papaya-on murine hepatic cytochrome P450 activities. J Appl Toxicol. 32(12):994–1001.
  • Choudhary MI, Nawaz SA, Ul-Haq Z, Lodhi MA, Ghayur MN, Jalil S, Riaz N, Yousuf S, Malik A, Gilani AH, et al. 2005. Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. Biochem Biophys Res Commun. 334(1):276–287.
  • Ding W, Cao C, Gao Y, Zhou X, Lai Y. 2020. Inhibition of CYP3A4 and CYP3A5 expression by scutellarin is not mediated via the regulation of hsa-miR-27a, 27b, 148a, 298 and 451a levels. Xenobiotica. 50(11):1267–1274.
  • Ding YY, Luan JJ, Fan Y, Olatunji OJ, Song J, Zuo J. 2020. α-Mangostin reduced the viability of A594 cells in vitro by provoking ROS production through downregulation of NAMPT/NAD. Cell Stress Chaperones. 25(1):163–172.
  • Foti RS, Pearson JT, Rock DA, Wahlstrom JL, Wienkers LC. 2009. In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract. Drug Metab Dispos. 37(9):1848–1855.
  • Fujii-Kuriyama Y, Mimura J. 2005. Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. Biochem Biophys Res Commun. 338(1):311–317.
  • Gao XY, Wang SN, Yang XH, Lan WJ, Chen ZW, Chen JK, Xie JH, Han YF, Pi RB, Yang XB. 2016. Gartanin protects neurons against glutamate-induced cell death in HT22 Cells: independence of Nrf-2 but involvement of HO-1 and AMPK. Neurochem Res. 41(9):2267–2277.
  • He G, Troberg J, Lv X, Xia YL, Zhu LL, Ning J, Ge GB, Finel M, Yang L. 2018. Identification and characterization of human UDP-glucuronosyltransferases responsible for xanthotoxol glucuronidation. Xenobiotica. 48(2):109–116.
  • Kim MO, Lee HS, Chin YW, Moon DO, Ahn JS. 2015. Gartanin induces autophagy through JNK activation which extenuates caspase-dependent apoptosis. Oncol Rep. 34(1):139–146.
  • Kokkonen P, Beier A, Mazurenko S, Damborsky J, Bednar D, Prokop Z. 2021. Substrate inhibition by the blockage of product release and its control by tunnel engineering. RSC Chem Biol. 2(2):645–655.
  • Li G, Petiwala SM, Yan M, Won JH, Petukhov PA, Johnson JJ. 2016. Gartanin, an isoprenylated xanthone from the mangosteen fruit (Garcinia mangostana), is an androgen receptor degradation enhancer. Mol Nutr Food Res. 60(6):1458–1469.
  • Liu D, Zheng X, Tang Y, Zi J, Nan Y, Wang S, Xiao C, Zhu J, Chen C. 2010. Metabolism of tanshinol borneol ester in rat and human liver microsomes. Drug Metab Dispos. 38(9):1464–1470.
  • Luo M, Liu Q, He M, Yu Z, Pi R, Li M, Yang X, Wang S, Liu A. 2017. Gartanin induces cell cycle arrest and autophagy and suppresses migration involving PI3K/Akt/mTOR and MAPK signalling pathway in human glioma cells. J Cell Mol Med. 21(1):46–57.
  • Moongkarndi P, Kosem N, Kaslungka S, Luanratana O, Pongpan N, Neungton N. 2004. Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J Ethnopharmacol. 90(1):161–166.
  • Nikolic D, Li Y, Chadwick LR, Grubjesic S, Schwab P, Metz P, van Breemen RB. 2004. Metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus), by human liver microsomes. Drug Metab Dispos. 32(2):272–279.
  • Nishimuta H, Nakagawa T, Nomura N, Yabuki M. 2013. Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans and rats or dogs. Xenobiotica. 43(11):948–955.
  • Pan Y, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Pook P C, Er HM, Ong CE. 2011. In vitro modulatory effects of Andrographis paniculata, Centella asiatica and Orthosiphon stamineus on cytochrome P450 2C19 (CYP2C19). J Ethnopharmacol. 133:881–887.
  • Pan Y, Tiong KH, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Ong CE. 2014. In vitro effect of important herbal active constituents on human cytochrome P450 1A2 (CYP1A2) activity. Phytomedicine. 21:1645–1650.
  • Pham V, Rendon R, Le VX, Tippin M, Fu DJ, Le TH, Miller M, Agredano E, Cedano J, Zi X. 2020. Gartanin is a novel NEDDylation inhibitor for induction of Skp2 degradation, FBXW2 expression, and autophagy. Mol Carcinog. 59(2):193–201.
  • Rastogi H, Jana S. 2014. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities. Phytother Res. 28:1873–1878.
  • Sakagami Y, Iinuma M, Piyasena KG, Dharmaratne HR. 2005. Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Phytomedicine. 12(3):203–208.
  • Savai J, Varghese A, Pandita N, Chintamaneni M. 2015. Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes. Phytother Res. 29:785–790.
  • Shan L, Zhang G, Guo Z, Shi X. 2019. In vitro investigation of permeability and metabolism of licoricidin. Life Sci. 234:116770.
  • Shi X, Zhang G, Ge G, Guo Z, Song Y, Su D, Shan L. 2019. In vitro metabolism of auriculasin and its inhibitory effects on human cytochrome P450 and UDP-glucuronosyltransferase enzymes. Chem Res Toxicol. 32(10):2125–2134.
  • Shi X, Zhang G, Mackie B, Yang S, Wang J, Shan L. 2016. Comparison of the in vitro metabolism of psoralidin among different species and characterization of its inhibitory effect against UDP- glucuronosyltransferase (UGT) or cytochrome p450 (CYP450) enzymes. J Chromatogr B Analyt Technol Biomed Life Sci. 1029-1030:145–156.
  • Shimada T, Mimura M, Inoue K, Nakamura S, Oda H, Ohmori S, Yamazaki H. 1997. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. Arch Toxicol. 71(6):401–408.
  • Uehara S, Uno Y, Yamazaki H. 2017. Hepatic expression of cytochrome P450 enzymes in non-human primate species. J Med Primatol. 46(6):347–351.
  • Wang Q, Qiao X, Liu CF, Ji S, Feng LM, Qian Y, Guo DA, Ye M. 2014. Metabolites identification of glycycoumarin, a major bioactive coumarin from licorice in rats. J Pharm Biomed Anal. 98:287–295.
  • Wei L, Locuson CW, Tracy TS. 2007. Polymorphic variants of CYP2C9: mechanisms involved in reduced catalytic activity. Mol Pharmacol. 72(5):1280–1288.
  • Xia YL, Dou TY, Lv X, Ge GB. 2019. In vitro characterization of the glucuronidation pathways of licochalcone A mediated by human UDP-glucuronosyltransferases. Xenobiotica. 49(6):671–677.
  • Ye H, Wang Q, Zhu F, Feng G, Yan C, Zhang J. 2020. Antifungal activity of alpha-mangostin against colletotrichum gloeosporioides in vitro and in vivo. Molecules. 25(22):5335.
  • Zhang F, Huang J, He RJ, Wang L, Huo PC, Guan XQ, Fang SQ, Xiang YW, Jia SN, Ge GB. 2020. Herb-drug interaction between Styrax and warfarin: molecular basis and mechanism. Phytomedicine. 77:153287.
  • Zhang F, Liu W, Huang J, Chen QL, Wang DD, Zou LW, Zhao YF, Zhang WD, Xu JG, Chen HZ, Ge GB. 2022. Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy. Acta Pharmacol Sin. 43(4):1072–1081.
  • Zhang YY, Liu Y, Zhang JW, Ge GB, Liu HX, Wang LM, Sun J, Yang L. 2009. C-7 configuration as one of determinants in taxanes metabolism by human cytochrome P450 enzymes. Xenobiotica. 39(12):903–914.
  • Zuber R, Anzenbacherova E, Anzenbacher P. 2002. Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med. 6(2):189–198.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.